243 / 490
241
POSTERS AND ELECTRONIC POSTERS
| PROGRAMME AND EXHIBITION GUIDE
ELECTRONIC POSTERS
> Can mucosal criteria estimate response in rectal cancer treated with
neoadjuvant chemoradiotherapy?
A. Garant (Canada), T. Niazi, A. Gologan, A. Spatz, J. Faria, N. Morin,
C. Vasilevsky, M. Boutros, T. Vuong
EP-1291
> Association between obesity and local control of rectal cancer after
surgery and radiotherapy
Y.S. Choi (Republic of Korea)
EP-1292
> Intensified neo-adjuvant chemoradiotherapy in locally advanced rectal
cancer: long-term follow-up
F. De Felice (Italy), D. Musio, A.L. Magnante, N. Bulzonetti, I. Benevento,
R. Caiazzo, V. Tombolini
EP-1293
> Total mesorectal excision vs. local excision following preoperative RT
for “early” cT3 rectal cancer
Y. Shin (Republic of Korea), J.H. Park, J.C. Kim, C.S. Yu, T.W. Kim,
J.H. Kim
EP-1294
> Anal cancer as a second human papillomavirus-related presentation
after cervical dysplasia/neoplasia
A. Yates (Australia), S. Pendlebury, E. Segelov
EP-1295
> A correlation between PTV dosimetric criteria and pathological
response in rectal cancer patients
A. Franzetti Pellanda (Switzerland), P. Urso, S. Gianolini, B. De Bari,
G. Ballerini, L. Negretti, C. Vite, N. Corradini
EP-1296
> Impact of 18F-FDG-PET/CT in evaluating the response to neadjuvant
chemoradiotherapy in rectal cancer
S. Pedraza Fernández (Spain), M. Pérez-Escutia, D. Sánchez-Fuentes,
P. Nenclares, S. Ruiz-Solís, M. Peña, D. Lora, J. Pérez-Regadera
EP-1297
> Stereotactic radiotherapy in oligometastatic patients with lung
metastasis from colon-rectal cancer
S. Montrone (Italy), C. Vivaldi, G. Coraggio, M. Cantarella, B. Manfredi,
C. Laliscia, G. Masi, F. Loupakis, A. Falcone, M.G. Fabrini, A. Sainato,
F. Pasqualetti
EP-1298
> Tomotherapy for anal cancer: analysis of toxicity and response in a dual
institution experience
P. Bonomo (Italy), B. Meduri, E. D’Angelo, A. Galardi, C. Delli Paoli,
C. Tata, G. De Marco, I. Desideri, F. Bertoni, L. Livi
EP-1299